ACE2: from vasopeptidase to SARS virus receptor.

ACE2: from vasopeptidase to SARS virus receptor.
复制标题

DOI:
10.1016/j.tips.2004.04.001
复制
发表时间:
2004-06
影响因子:
13.8
通讯作者:
Hooper NM
Hooper NM
中科院分区:
医学1区
文献类型:
--
作者:
Turner AJ;Hiscox JA;Hooper NM

文献摘要

参考文献

被引文献

相似文献

锌金属肽酶血管紧张素转换酶2(ACE 2)是唯一已知的血压血管紧张素转换酶(ACE)的关键调节因子的人类同源物。自2000年发现以来,ACE 2与心脏功能、高血压和糖尿病有关,其作用部分通过其将血管紧张素II转化为血管紧张素-(1-7)的能力介导。出乎意料的是,ACE 2也是严重急性呼吸综合征(SARS)病毒的细胞进入点,因此该酶是几种疾病前沿药物干预的主要靶点。
The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being mediated, in part, through its ability to convert angiotensin II to angiotensin-(1–7). Unexpectedly, ACE2 also serves as the cellular entry point for the severe acute respiratory syndrome (SARS) virus and the enzyme is therefore a prime target for pharmacological intervention on several disease fronts.
DOI: 10.1016/s0168-1702(03)00160-6
发表时间: 2003-09
期刊: Virus research
影响因子: 5
作者:
Hiscox JA
通讯作者: Hiscox JA
DOI: 10.1038/nature02145
发表时间: 2003-11-27
期刊: Nature
影响因子: 64.8
作者:
Li W;Moore MJ;Vasilieva N;Sui J;Wong SK;Berne MA;Somasundaran M;Sullivan JL;Luzuriaga K;Greenough TC;Choe H;Farzan M
通讯作者: Farzan M
DOI: 10.1038/nrd1227
发表时间: 2003-11
期刊: Nature reviews. Drug discovery
影响因子: --
作者:
Acharya KR;Sturrock ED;Riordan JF;Ehlers MR
通讯作者: Ehlers MR
DOI: 10.1021/bi035268s
发表时间: 2003-11-18
期刊: BIOCHEMISTRY
影响因子: 2.9
作者:
Guy, JL;Jackson, RM;Turner, AJ
通讯作者: Turner, AJ
DOI: 10.1021/ja0277226
发表时间: 2002-10-09
影响因子: 15
作者:
Dales, NA;Gould, AE;Patane, MA
通讯作者: Patane, MA